Friday, March, 2012
Please note that CME credit for this program required in-person attendance. Viewing these presentations online does not qualify for CME credit.
Therapeutic Targeting of Cancer Cell Metabolism in Lymphoid Neoplasia
Chi Van Dang, MD, PhD
Update in MGUS, Smoldering Myeloma and Amyloidosis
Brendan M. Weiss, MD
Experimental Therapies for Relapsed Myeloma
Dan Vogl, MD
Latest Transplant Approaches for Myeloma
Edward A. Stadtmauer, MD
Update in Approach to MDS and Elderly AML
Selina Luger, MD
Experimental Therapies for Leukemia
Margaret T. Kasner, MD
Latest Update in Myeloproliferative Diseases
Elizabeth O. Hexner, MD
Updates in Kinase Inhibition for Leukemia
Alexander Perl, MD
New Approaches to Allogeneic Stem Cell Transplant
Ran Reshef, MD
At the Frontier of Cellular Therapy for Blood Cancers
David L. Porter, MD
Long Term Survivorship Issues in Transplantation
Alison W. Loren, MD
Laboratory Medicine: Genetics of Lymphoid Neoplasms
Gerald B. Wertheim, MD, PhD
New Therapies and Current Management of Follicular Lymphomas and CLL
Stephen J. Schuster, MD
Therapeutic Advances in Hodgkin Lymphoma
Jakub Svoboda, MD
New Therapies for Mantle Cell and T-cell Lymphomas
Sunita D. Nasta, MD
Current Treatment for Aggressive Lymphomas
Mitchell Smith, MD, PhD
